Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;50(4):768-72.
doi: 10.1194/jlr.D800050-JLR200. Epub 2008 Dec 5.

Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR

Affiliations

Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR

Matthew B Lanktree et al. J Lipid Res. 2009 Apr.

Abstract

Plasma lipoprotein(a) [Lp(a)] concentration is related to risk of cardiovascular disease. The defining protein component of Lp(a) particles, apolipoprotein(a) [apo(a)], is encoded by the LPA gene. Apo(a) is extremely heterogeneous in size due to a common copy number variation, leading to a variable number of kringle-IV type 2 (KIV2)-like domains. Alleles with fewer KIV2 repeats, encoding smaller apo(a) isoforms, are associated with higher plasma Lp(a) concentrations. Two principal methods to detect variation in KIV2 repeat number are electrophoresis with immunoblotting to detect apo(a) protein isoforms or pulse-field electrophoresis of unamplified genomic DNA to detect the variation of the LPA gene. Both methods are technically challenging, laborious, and time consuming. Here, we report a rapid method to determine the number of KIV2 repeats in LPA from genomic DNA using quantitative real-time polymerase chain reaction (qPCR). With qPCR, we found KIV2 repeat number was correlated with both apo(a) isoform size as determined by immunoblotting (r(s) = 0.50, P < 1 x 10(-6)) and with plasma Lp(a) concentration (r(s) = 0.30, P < 1 x 10(-6)). The qPCR technique permits rapid evaluation of apo(a) size from genomic DNA, and thus would provide an adjunctive genomic variable, in addition to LPA single nucleotide polymorphisms, for evaluating the genetic determinants of plasma Lp(a) concentration in genetic epidemiology studies of cardiovascular disease outcomes.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
A: Gene structure and linkage disequilibrium (LD) plot of LPA locus generated using HapMap CEPH (Centre d'Etude du Poymorphisme Humain) data. Red boxes indicate areas of complete LD, white boxes indicate areas of recombination, and blue boxes are uninformative areas. Exons are indicated by black boxes with every fifth exon labeled in top track. Physical position and exon numbers are taken from National Centre for Biotechnology Information reference sequence build 36.3. Kringles with sequence homology with the fourth plasminogen kringle (KIV) and fifth plasminogen kringle (KV) are indicated. Each kringle is encoded by two exons. B: Amino acid alignment showing sequence homology between kringle repeats.
Fig. 2.
Fig. 2.
Correlation observed between the two probes found within the kringle-IV type 2 (KIV2) repeat: Δcycle thresholds (CT) CT4, the probe found in exon 4, and ΔCT5, the probe found in exon 5.
Fig. 3.
Fig. 3.
The relationship between apolipoprotein(a) [apo(a)] isoform as identified by PAGE and immunoblotting and formula image from quantitative real-time polymerase chain reaction (qPCR).
Fig. 4.
Fig. 4.
The relationship between plasma of lipoprotein(a) [Lp(a)] concentration and formula image from qPCR.

References

    1. Ridker P. M., C. H. Hennekens, and M. J. Stampfer. 1993. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA. 270 2195–2199. - PubMed
    1. Rhoads G. G., G. Dahlen, K. Berg, N. E. Morton, and A. L. Dannenberg. 1986. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 256 2540–2544. - PubMed
    1. Ohira T., P. J. Schreiner, J. D. Morrisett, L. E. Chambless, W. D. Rosamond, and A. R. Folsom. 2006. Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 37 1407–1412. - PubMed
    1. Moliterno D. J., E. V. Jokinen, A. R. Miserez, R. A. Lange, J. E. Willard, E. Boerwinkle, L. D. Hillis, and H. H. Hobbs. 1995. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler. Thromb. Vasc. Biol. 15 850–855. - PubMed
    1. Rosengren A., L. Wilhelmsen, E. Eriksson, B. Risberg, and H. Wedel. 1990. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ. 301 1248–1251. - PMC - PubMed

Publication types